Exploring how ketosis, 30 g of MCT oil, and NAD+ restoration may reshape brain energy and cognition in Alzheimer’s disease
Alzheimer’s disease appears increasingly like a brain energy crisis, where neurons starve despite abundant fuel in the bloodstream. Most evidence suggests that boosting NAD+ and supporting nutritional ketosis, often with MCT oil, can improve brain energy metabolism and some Alzheimer’s–related changes, but this has not yet been proven to reliably “reverse” Alzheimer’s in humans. Many of the strongest “reversal” findings come from animal and cellular models, while human data point to promising but still limited cognitive benefits.
Alzheimer’s as an Energy Crisis
Alzheimer’s is now often framed as a disorder of impaired brain fuel use, not just a buildup of amyloid and tau. Neurons in affected brain regions lose their ability to efficiently use glucose, which has led researchers to describe Alzheimer’s as a form of “type 3 diabetes” of the brain. This mismatch between fuel supply and fuel use severely strains mitochondria, the cell’s power plants, and accelerates oxidative damage, inflammation, and cell death.
Compounding this energy problem is a gradual decline in NAD+ (nicotinamide adenine dinucleotide), a central cofactor involved in energy production and cellular repair. With age and in neurodegenerative conditions, NAD+ levels fall, leaving mitochondria less capable of generating ATP and cells less able to repair DNA damage or maintain healthy protein quality control. In Alzheimer’s brains, this drop in NAD+ appears to be tied closely to mitochondrial dysfunction, rising oxidative stress, and synaptic failure, all of which contribute to progressive memory loss.
What NAD+ Does in the Brain
NAD+ is a critical molecular “hub” that supports both energy production and resilience under stress. In its oxidized (NAD+) and reduced (NADH) forms, it shuttles electrons through metabolic pathways, allowing mitochondria to make ATP efficiently. Beyond its role in energy, NAD+ serves as a substrate for enzymes such as sirtuins and PARPs, which regulate mitochondrial biogenesis, antioxidant defenses, inflammation, and DNA repair.
When NAD+ levels fall, the brain’s ability to handle metabolic stress and repair damage declines. Experimental studies in Alzheimer’s models show that restoring NAD+ can reverse several pathological features. In transgenic Alzheimer’s mice, supplementation with the NAD+ precursor NMN has been shown to improve mitochondrial quality control and mitophagy, reduce markers of amyloid processing, and lessen hippocampal neuron loss and brain atrophy. Behavioral testing in these animals has revealed better spatial learning and memory after NMN treatment, suggesting that NAD+ repletion can translate into functional gains.
Other work using NAD+ precursors such as NR (nicotinamide riboside) indicates that boosting NAD+ can normalize aberrant RNA splicing and other cellular processes disrupted in Alzheimer’s. Collectively, these experiments point to NAD+ as a lever that can, at least in animal models, partially “rejuvenate” neuronal metabolism and connectivity.
Ketosis, MCT Oil, and NAD+/NADH
Ketosis offers the Alzheimer’s brain a way to bypass its dependence on glucose. In mild to moderate Alzheimer’s disease, imaging studies show that while glucose uptake in the brain declines, uptake of ketone bodies (beta‑hydroxybutyrate and acetoacetate) remains relatively preserved. When a person is in ketosis—through diet, fasting, or supplements—the liver produces ketones that can substitute as an alternative fuel.
MCT (medium‑chain triglyceride) oil is a practical tool for raising ketones quickly, because medium‑chain fats are transported directly to the liver and converted into ketones. Even modest doses of MCT oil can elevate blood ketone levels within 30–60 minutes, and larger or repeated doses can help maintain this alternative fuel supply over the day. In the context of Alzheimer’s, this extra ketone availability may partially compensate for the brain’s impaired use of glucose and support neuronal function in vulnerable regions involved in memory.
Metabolically, ketone use is also more favorable for NAD+ balance than glucose use. Glycolysis, the pathway that breaks down glucose, involves several steps that depend on NAD+, which can strain limited NAD+ pools in aging or diseased cells. Ketone oxidation requires fewer NAD+‑dependent steps, effectively “sparing” NAD+ and increasing the NAD+/NADH ratio. Small human studies indicate that MCT‑induced ketone production can lead to measurable increases in brain NAD+ and in the NAD+/NADH ratio within under an hour, suggesting that ketosis can rapidly shift redox balance in a direction associated with healthier mitochondrial function.
Why Being in Ketosis Matters for Alzheimer’s
Sustained nutritional ketosis—whether through a ketogenic diet, intermittent fasting, exogenous ketones, or regular MCT oil intake—appears to support the Alzheimer’s brain through several mechanisms:
- Alternative fuel supply
Ketones provide a direct energy source to neurons that can no longer rely fully on glucose. This can help maintain synaptic activity, support plasticity, and reduce the severity of the energy shortfall in key cognitive circuits. - Improved NAD+ balance and mitochondrial efficiency
Because ketone metabolism uses less NAD+ per unit ATP produced, being in ketosis shifts the NAD+/NADH ratio toward a more oxidized, energy‑efficient state. This favors better mitochondrial respiration, reduced reactive oxygen species production, and improved activation of NAD+‑dependent enzymes involved in cellular repair. - Anti‑inflammatory and signaling effects
Ketones like beta‑hydroxybutyrate also function as signaling molecules. They can inhibit inflammatory machinery such as the NLRP3 inflammasome and modulate gene expression via epigenetic mechanisms. These signaling effects may lower neuroinflammation, a significant driver of neurodegeneration in Alzheimer’s disease. - Synaptic and cognitive benefits
In both animal models and small human studies, ketogenic interventions have been associated with improved performance on memory tests and better daily function in some patients with mild cognitive impairment or mild to moderate Alzheimer’s. While not universal, these responses suggest that ketosis can translate metabolic advantages into real‑world cognitive changes for at least a subset of individuals.
Focusing on 30 g of MCT Oil
A frequently discussed practical approach is to use around 30 g of MCT oil per day to help maintain ketosis, especially for people who are unable or unwilling to follow a strict ketogenic diet. This dose level, often divided across meals, is common in clinical anecdotes and some small trials, though definitive large‑scale studies are still lacking.
Rationale for 30 g
Lower doses of MCT oil, such as 5–10 g, are sufficient to raise ketone levels and have been shown to measurably affect brain metabolism. However, higher daily intakes—20–30 g or more—may be needed to maintain a more consistent level of ketosis throughout the day in people who are eating a moderate‑carbohydrate diet. For an Alzheimer’s patient, the clinical goal is not a single ketone spike but a relatively stable supply of ketones that can continually feed vulnerable neurons and maintain a favorable NAD+/NADH ratio.
At around 30 g per day, many individuals can reach and sustain mild to moderate ketosis, depending on their overall diet, body mass, and activity level. This level of ketone availability may be sufficient to materially improve brain energy status and complement other treatments aimed at stabilizing cognition.
Dosing, Tolerance, and Safety
MCT oil can cause gastrointestinal discomfort, including nausea, cramping, and diarrhea, especially if introduced abruptly at higher doses. For that reason, most protocols emphasize a slow titration strategy:
- Start with small doses (for example, 5 g once or twice daily with food).
- Gradually increase the dose every few days as tolerated, aiming for a total of up to 30 g per day.
- Split the total daily dose into two or three servings, often aligned with meals or times when cognitive demands are high.
Older adults, and especially those with frailty or multiple medical conditions, should only attempt dose escalation under medical supervision. Clinicians may monitor weight, hydration, liver function, lipid profile, and any interactions with existing medications.
NAD+ Boosting, Ketosis, and “Reversing” Alzheimer’s
The claim that “NAD+ boosting reverses Alzheimer’s” reflects very compelling data from preclinical research, but translation to humans is still in its early stages.
Evidence from Animal and Cellular Models
In mice engineered to develop Alzheimer’s‑like pathology, boosting NAD+ with precursors such as NMN has shown impressive results. Treated animals often exhibit:
- Reduced mitochondrial stress and improved mitophagy.
- Decreased accumulation of amyloid‑related proteins and better synaptic integrity.
- Less neuronal loss in the hippocampus and other critical regions.
- Measurable improvements in learning and memory tasks.
In additional models spanning worms, mice, and human cell systems, NAD+ repletion has been found to correct disrupted RNA splicing and other molecular alterations tied to Alzheimer’s. Some of these studies show that NAD+ interventions can be effective even when applied at more advanced disease stages, which supports the idea of genuine “reversal” of pathology in these systems rather than mere prevention.
What Is Known in Humans
In humans, the evidence is much more limited but encouraging:
- Small clinical trials and open‑label studies with ketogenic diets, exogenous ketones, or MCT‑based medical foods have reported modest improvements in cognitive testing, particularly in people with mild to moderate disease and in certain genetic subgroups.
- Case reports and series suggest that some individuals can experience noticeable improvements in memory, attention, and daily functioning after adopting a well‑structured ketogenic regimen or regular MCT supplementation.
- NAD+ precursors such as NR and NMN have been tested primarily for safety and metabolic effects in humans, showing the ability to raise NAD+ levels and influence mitochondrial markers, but large Alzheimer’s‑specific outcome trials are still pending.
Taken together, these data do not yet justify broad claims of reliable Alzheimer’s “reversal” in humans. Instead, they point to NAD+ boosting and ketosis—via lifestyle and MCT oil—as promising tools that may slow disease progression or produce partial, individualized improvements.
Integrating Ketosis, 30 g MCT, and NAD+ Strategies
A research‑informed, conceptual approach for someone with Alzheimer’s or at high risk might include several coordinated elements (always under clinician guidance):
- Establish nutritional ketosis
Shift toward a lower‑carbohydrate, higher‑healthy‑fat diet, possibly combined with time‑restricted eating or intermittent fasting, to promote endogenous ketone production and activate NAD+‑linked pathways. - Use MCT oil strategically (up to ~30 g/day)
Introduce MCT oil gradually, increasing toward a target of roughly 30 g per day in divided doses as tolerated, to sustain mild to moderate ketosis. Pair doses with times of day when cognitive performance matters most. - Directly support NAD+
Consider NAD+ precursors such as NMN or NR under clinical oversight, along with lifestyle measures known to preserve NAD+ (regular movement, good sleep, minimal alcohol, and avoidance of highly processed foods). - Combine with comprehensive care
Continue established Alzheimer’s care, including medications when appropriate, cognitive therapy, physical activity, and management of vascular risk factors. Metabolic strategies should be viewed as an adjunct, not a replacement, for evidence‑based medical care.
Future Directions and Remaining Questions
The intersection of NAD+ biology, ketosis, and neurodegeneration is an active research frontier. Several key questions remain:
- Which patients are most likely to benefit from NAD+ augmentation and ketogenic strategies—by age, genetics, disease stage, or comorbidities?
- What are the optimal doses, timing, and combinations of NAD+ precursors and ketogenic interventions (including 30 g MCT oil) for long‑term cognitive benefit?
- Can large randomized controlled trials demonstrate not only slowed decline but robust functional recovery that merits the label “reversal” of Alzheimer’s in everyday life?
Until those questions are answered, it is prudent to view NAD+ boosting and ketosis as powerful, biologically plausible tools within a broader therapeutic toolkit. For some people, especially in earlier stages, these strategies may offer meaningful improvements in quality of life and daily functioning, even if they do not fully undo all aspects of the disease.
References (Brief Descriptions and URLs)
- NAD+ in Alzheimer’s Disease: Molecular Mechanisms and Therapeutic Potential
Review article discussing how NAD+ decline contributes to Alzheimer’s pathology and how NAD+‑boosting strategies might help.
URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC8369418/ - NAD+-boosting agent nicotinamide mononucleotide potently attenuates Alzheimer’s disease‑like pathology in mice
Animal study showing that NMN improves mitochondrial function, reduces pathology, and enhances cognition in Alzheimer’s‑model mice.
URL: https://www.nature.com/articles/s41419-024-07062-1 - NAD+ reverses Alzheimer’s neurological deficits via regulating RNA metabolism
Research revealing how NAD+ restoration can correct RNA splicing defects and reverse neuronal dysfunction across multiple AD models.
URL: https://www.science.org/doi/10.1126/sciadv.ady9811 - NAD+ Revives Memory In Alzheimer’s Models
News and expert summary outlining recent findings on how NAD+ supplementation can improve memory in experimental Alzheimer’s models.
URL: https://www.psychiatrist.com/news/nad-revives-memory-in-alzheimers-models/ - Nutritional Ketosis May Preserve Brain Health via Increasing the NAD+/NADH Ratio
Article summarizing research on how ketosis and MCT oil impact brain energy metabolism and the NAD+/NADH ratio in humans.
URL: https://www.metagenicsinstitute.com/articles/nutritional-ketosis-may-preserve-brain-health-via-increasing-nad-nadh-ratio/ - NAD+ in Brain Aging and Neurodegeneration (Review)
Broader review of NAD+ biology in brain aging and how strategies to restore NAD+ may apply to conditions like Alzheimer’s.
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369418/ (same main review, alternate access link) - Keto and MCT for Alzheimer’s – One Doctor’s Family Journey (Video)
Clinically oriented video describing practical use of ketogenic diets and MCT oil in Alzheimer’s care, with anecdotal outcomes.
URL: https://www.youtube.com/watch?v=r3-5GQfeJ68 - Hundreds Report Dementia Improvement with Ketones (Video)
Video discussing case experiences and emerging evidence on ketone‑based interventions in dementia.
URL: https://www.youtube.com/watch?v=EmkvmRW0yVc - New study shows Alzheimer’s disease can be reversed to achieve full neurological recovery (News)
Recent news coverage of cutting‑edge research suggesting that restoring metabolic balance, including NAD+, can reverse advanced AD in animal models.
URL: https://case.edu/news/new-study-shows-alzheimers-disease-can-be-reversed-achieve-full-neurological-recovery-not-just-prevented - Alzheimer’s disease could be reversed by restoring brain balance (News)
Article summarizing new research on rebalancing brain networks and metabolism in Alzheimer’s, including NAD+‑related mechanisms.
URL: https://www.foxnews.com/health/alzheimers-disease-could-reversed-restoring-brain-balance-study-suggests